Test Price
1,700 AED✅ Home Collection Available
Candida Multiplex RNA Detection Panel in UAE | 1700 AED | DHA-Licensed Laboratory
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited Reverse Transcription Real-Time PCR (RT-qPCR) with melt curve analysis – definitive species-level resolution for 8 Candida pathogens.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM) for blood samples. Hospital extraction required for BAL, tissue biopsies, and bone marrow.
- Clinical Guidance: Complimentary telephonic post-test interpretation by DHA-licensed clinical experts.
- Insurance: Direct billing verification via WhatsApp: +971 54 548 8731.
Test Overview & Methodology
The Candida Multiplex RNA Detection Panel identifies and differentiates eight clinically relevant Candida species—including C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, C. nivariensis, C. dubliniensis, and C. lusitaniae—directly from blood, BAL, fresh tissue biopsies, and respiratory secretions using ultra-sensitive RT-qPCR. This qualitative RNA-based assay enables targeted antifungal therapy by detecting active transcription, providing a superior alternative to traditional culture methods that often fail for fastidious or slow-growing species.
| Feature | Our Test (RT-qPCR) | Closest Alternative (Fungal Culture) |
|---|---|---|
| Methodology | Reverse Transcription Real-Time PCR with species-specific probes | Sabouraud agar / chromogenic culture |
| Species Differentiation | 8 species simultaneously, including cryptic C. nivariensis | Preliminary ID; often requires MALDI-TOF or sequencing |
| Speed to Result | Phone result in 36 hours | 3–7 days, slower for non-albicans |
| Sensitivity (active infection) | 99.9% (detects viable organisms via RNA) | ~70% (often suppressed by prior antifungals) |
Physician Insight & Safety Protocols
“A positive RNA detection of Candida in deep tissue or sterile sites is a critical finding that must be correlated with clinical signs, host immune status, and radiological evidence. This test is a powerful tool for guiding pre-emptive therapy, but it does not replace a comprehensive infectious disease consult. Patients should continue prescribed antifungal or supportive medication unless their treating physician advises a change.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Advisory – Medication Continuation
Do Not Alter Prescribed Therapy
Never discontinue or modify any prescribed antifungal, immunosuppressive, or other medication without direct consultation with your supervising physician. Premature cessation can lead to disease progression or antifungal resistance.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Inability to provide a valid signed consent form; lack of accompanying clinical history or prior antifungal exposure documentation.
- Sample Rejection: Improperly labelled or transported specimens (non-cold chain), clotted blood, or formalin-fixed tissue.
- Red Flag Symptoms: If you experience high-grade fever, severe hypotension, altered mental status, or new skin nodules while awaiting results, proceed to the nearest emergency department immediately.
- Pediatric/Minor Consent: Testing of minors requires documented guardian consent and DHA-compliant assent procedures in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What does the Candida Multiplex RNA Panel detect and why is RNA preferred?
Direct 15-word summary: It detects RNA from eight Candida species, confirming active viable infection with exceptional 99.9% sensitivity.
RNA degrades rapidly after cell death, so its presence strongly indicates living, metabolically active organisms—this is crucial for distinguishing true invasive candidiasis from colonization or contamination. The panel covers common species and emerging pathogens like C. nivariensis, helping your doctor choose the most effective targeted antifungal.
2. How should I prepare for sample collection, and what specimens are accepted?
Direct 15-word summary: Bring your clinical history and signed consent; blood, BAL, fresh biopsy, and respiratory samples accepted.
No fasting is required for most samples; however, for tissue biopsies and bronchoalveolar lavage, the procedure will be performed by your physician. Our phlebotomy team handles blood draws using cold-chain transport. All samples must be accompanied by a duly filled requisition and consent form. Please disclose any current antifungal therapy to avoid false negatives.
3. How long for results and what does a positive result mean?
Direct 15-word summary: Phone result in 36 hours, email in 48; a positive indicates active Candida infection.
You will receive a preliminary verbal report within 36 hours and the formal PDF report by email on the 4th working day. A positive detection of one or more species mandates immediate clinical correlation—it does not automatically confirm invasive disease unless compatible symptoms exist. Your physician will interpret the result in the context of cultures, imaging, and host factors.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and adheres strictly to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data are encrypted, access-controlled, and processed exclusively within UAE jurisdiction. Clinical safety and patient consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | Candida Multiplex RNA Detection Panel |
| Price (AED) | 1700 AED |
| Turnaround Time | 36–48 hours (verbal report within 36 hours; formal PDF report by email on 4th working day) |
| Sample Type / Matrix | Whole blood (EDTA), bronchoalveolar lavage (BAL), fresh tissue biopsy (skin, brain, eye, bone, lung, cardiac valve, bone marrow), respiratory secretions. Hospital Extraction Only for BAL, tissue biopsies, and bone marrow – sample collection conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for these specimen types. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available for blood samples (daily 8 AM – 11 PM). |
| Methodology Used | Reverse Transcription Real-Time PCR (RT-qPCR) with species-specific probes and melt curve analysis |
| ICD-10-CM Code | B37.9 (Candidiasis, unspecified) |
| LOINC Code | 103459-2 (Candida species DNA [Presence] in Blood by NAA with probe detection) |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians